is gone fishing
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Now NITE is on the bid and the ask at .0001 cause nobody hit the ask when at .0002
NITE is now on the bid at .ooo1 we need someone to hit the ask at .0002 and we will officially have the bid back.
Nice! lets take out ETMM ask at .039
Bid now .0008 x 3 ask .001 x 3
then the ask is thin only 3 mm in front of .002
Hey JIM BICKEL, Look!!!!
The International PIPEs Conference 2009
March 23-25, 2009
Pudong Shangri-La - Shanghai, China
In 2009, Shanghai plays host to The International PIPEs Conference & RoadShow, the most influential event for cross-border investment between the U.S. and China.
The 2009 event will offer technical education on laws and deal structures, company presentations, networking, and opportunities to visit with Chinese-based companies seeking financing
No! But thanks for the idea I"ll try that.
If that doesn't work can I borrow some money for the bus?
I here the short bus goes to Murrieta where Andy lives. tia
I agree, If S3 closes another Reverse Merger/ENHD starts trading. This investment will be extremely profitable for all. JMHO GLTUA
Hi Goalie, Andy hasn't answered the phone in the past few days. Have at it! GL
GM, I agree if JB would just communicate with the shareholders it would go a long ways. GLTUA
I'll guess $5.60
Thanks Rain, This is a new world for me.
I'm learning so much I think my head is going to explode!
Never mind found in the sec files!
Thanks, Where did you obtain this info?
Not in my links!
Can't win em all!Have you seen SCII?
SCII:US
Stem Cell Therapy International Inc
Stem Cell Therapy International Inc. Announces Major Obstacles
Stem Cell Therapy International Inc. Announces Major Obstacles Cleared for Merger With Histostem
Histostem Litigation Resolved Favorably - Negotiating Terms for Necessary Financing - Established Relationship With Clinic in Mexico - Imminent Execution of Strategic Plan
TAMPA, FL -- (MARKET WIRE) -- 12/11/08 -- Stem Cell Therapy International Inc. (OTCBB: SCII)
-- HISTOSTEM LITIGATION RESOLVED FAVORABLY
-- NEGOTIATING TERMS FOR NECESSARY FINANCING
-- ESTABLISHED RELATIONSHIP WITH CLINIC IN MEXICO
-- IMMINENT EXECUTION OF STRATEGIC PLAN
Stem Cell Therapy International Inc. (SCII), announces today that the Company is in the final stages of completing the merger between Stem Cell Therapy International, Inc. (the "Company" or "AmStem International"), and the Histostem Corporation, Ltd (Korea), which has been filed previously with the SEC.
The Company continues to coordinate with Histostem to finalize the details of the merger between the two companies, which is expected to be completed shortly. In addition, the Company is working with several investors to negotiate terms to obtain the necessary investment capital, which will enable management to implement its strategic growth initiatives, and begin creating revenue almost immediately.
A mStem International, the newly named company resulting from the merger of Stem Cell Therapy International, Inc., and HistoStem, Ltd. of Korea, will soon be the primary resource for scientific Stem Cell research by pioneering the bio-resource bridge between Asia and the United States. Histostem operates the largest accredited Cord Blood & Stem Cell bank in the world (more than twice as large as its nearest competitor), and is already successfully treating patients with its patented, Korean FDA-approved Stem Cell therapies.
"This is a truly auspicious development," says David Stark, President of Stem Cell Therapy International, Inc. "Now all parties are completely unencumbered to combine resources and become the world leader in several strategic growth market sectors: Cord Blood banking, Stem Cell therapy, the highest quality Biological Repository for science, and development of our own products."
At the recent World Stem Cell Summit held in Madison, Wisconsin, Dr. Stark forged a relationship with a U.S. company, Cancun Stem Cell Clinic, Inc. with a stem cell clinic in Cancun, Mexico, which will enable the Company to conduct IRB approved clinical studies under ICH and FDA approved guidelines. The clinic will be operated by a team of highly trained American and Mexican staff, utilizing Cancun Stem Cell Clinic, Inc., state-of-the-art facility and Histostem's proven therapeutic models.
David Stark, Chief Executive Officer, states, "Although it has been a challenge to make significant progress while the Company was awaiting the jury verdict in the Histostem litigation, we have created a great foundation with the Cancun Stem Cell Clinic, Inc., in Cancun, Mexico, which should enable us to accelerate our growth strategy after we complete the merger and obtain the necessary financing."
As AmStem International, the Company plans to leverage Histostem's technology to be the state-of-the-art conduit for bringing Asian adult Stem Cells into the U.S. for clinical trials and the treatment of conditions on which Americans spend billions of dollars annually. This is predicated on successful clinical trial results for Male Pattern Baldness, Buerger's Disease and other conditions in Korea by Histostem, whose repository of over 80,000 Cord Blood Units has consistently met the rigorous standards of the Korean FDA. This has made Histostem the largest repository of Cord Blood in the world, and one of the first to actually profit from sales of its own Stem Cell-derived products. This ensures a faster than usual revenue stream for the new company.
About Stem Cell Therapy International, Inc.
Stem Cell Therapy International, Inc. (OTCBB: SCII) is in the field of regenerative medicine. SCII is a company devoted to the treatment of patients with stem cell transplantation therapy as well as providing the supplies o f biological solutions containing new lines of stem cell products. Further information about Stem Cell Therapy International, Inc. can be found at its website www.scticorp.com.
About Histostem Corporation, Ltd:
Histostem, Co., Ltd. started in Seoul, Korea in 2000. To date it has treated more than 500 patients with stem cells and currently have 56 full-time employees and 28 part-time employees. Histostem's intellectual property portfolio consists of five patents that have been granted and 6 patents pending. To its knowledge, Histostem is one of the very few stem cell companies in the world currently earning several million dollars in income from its products and technology. A comprehensive list of Histostem's achievements can be found at the company's website http://www.histostem.co.kr (click on English version when entering the site).
Forward-Looking Statements
Some of the statements included in this press release, particularly those anticipating future clinical and business prospects for Stem Cell Therapy International, Inc., may be forward-looking statements that involve a number of risks and uncertainties. For those statements, we claim the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995. Among the factors that could cause our actual results to differ materially are the following: our ability to obtain necessary capital, our ability to successfully complete the merger, successfully complete clinical trials; our ability to meet anticipated development timelines, our ability to establish global market for the cord blood cells, clinical trial results, successfully consummate future acquisitions, manufacturing capabilities or other factors; and other risk factors identified from time to time in our reports filed with the Securities and Exchange Commission. Any forward-looking statements set forth in this press release speak only as of the date of this press release. We do not intend to update any of these forward-looking statements to reflect events or circumstances that occur after the date hereof.
Company Contact: Stem Cell Therapy International, Inc. David Stark President Info@scticorp.com
Last Updated: December 11, 2008 13:00 EST
Thanks, watching those for a while.
I need to stop watching and jump in soon.lol
This ones been on my Watchlist!
http://www.bloomberg.com/apps/quote?ticker=GMDTF%3AUS
Good job Ten!
Back now! someone got some cheapies at .0006
Bid is now:
.0006 x 4
ask is now:
.0008 x 1
.0009 x 1
.001 x 1
.0011 x 1
.0013 x 1
.0014 x 1
GM Sith, I think SIVC is going to surprise many this year.
"watched water does Not boil" Come back after ENHD starts trading.GLTU
755,000 vol. bid is now .0008 x 1 ask .001 x 2
Thanks Myth, Great job! Things can only get better as SIVC progresses.
Happy New Year to All!
Let's Rain a Dime in '09
Best Copper
Here it is for USA.
http://www.bloomberg.com/apps/quote?ticker=AECFF%3AUS
Here it is for CN
http://www.bloomberg.com/apps/quote?ticker=AEC%3ACN
Buys 805,904 vs sells 267,250
North we go IMHO
http://ih.advfn.com/p.php?pid=trades&cb=1230601672&symbol=NO^ZLNK&java_vm=sun&java_vm_ver=1.6.0_04&fp=9.0.124
Hope your family member has a 100% recovery.
Amazing story! She had remarkable control both physical and mental during her stroke.
Amazing control reminded me of this video. Hope you can enjoy.
http://www.ebaumsworld.com/video/watch/824123/
Great post, Down to earth! I agree, you never Know what the future will bring. It simply Is'nt over until the fat lady sings and in SIVC's case the fat lady has'nt even stepped on stage yet. GLTUA
Sweeeeeet! I'm ready for the trip north.
Thanks Rich, That makes sense.
Does'nt show up on my E-signals at all.
So it's not dilution or a transfer of shares.
Checked Nasdaq and nothing "Weird"
Something is up 72,500 ? vol. does'nt show up anywhere but here.
http://ih.advfn.com/p.php?pid=trades&cb=1230310049&symbol=NO%5EZLNK
Wow! Thanks Rain, and Merry X-mas!
Thanks Rain, Sounds Great! Now we wait while we accumulate.
Goog,Nasdaq,Bloomberg and Aol. all tell me ZLNK is a pink or otc. also told me Yahoo is a POS. lol
btw: MERRY X-MAS & HAPPY HOLIDAYS
Ask is thin to .02
NITE .016 x 5000 PERT .019 X 5000
THEN 3 MMS @ .02
ZLNK Trend spotter -buy
short Term Indicators Average: 100% buy
Medium Term Indicators Average: 100% buy
Long Term Indicators Average: 100% buy
http://quote.barchart.com/texpert.asp?sym=zlnk&code=BSTK
Hi Myth, Just noticed new mod. over here Congrats.
A gift perhaps for the I-box.
Reuters Media
Financial Products
About Thomson ReutersEnergroup Holdings Corporation Acquires Chinese Pork Processor Dalian Chuming(TM)...
Mon Jan 7, 2008 9:28am EST
in Share Exchange Accompanied by $17.0 Million Private Placement
DALIAN, China, Jan. 7 /Xinhua-PRNewswire-FirstCall/ -- On December 31,
2007, Energroup Holdings Corporation (OTC Bulletin Board: ENHD), a Nevada
corporation (the "Company"), acquired all of the issued and outstanding
capital stock of Precious Sheen Investments Limited, a British Virgin Islands
corporation ("PSI") and parent company of PRC-based Dalian Chuming, a pork
processing company with USD $70.4 million in sales in 2006, and USD $89.7
million in unaudited sales in the first three quarters of 2007. The
acquisition was accomplished by means of a share exchange in which the former
shareholders of PSI were issued a controlling stake in the Company.
Dalian Chuming, with its Chuming(TM) brand food products, is the second
largest pork processor in both the Liaoning Province and the Northeast Region
of the People's Republic of China, a region with a population of 108 million
people. The Company is ISO 9001 and HACCP certified, maintains industrialized
hog slaughtering, processing and distribution facilities and is known for its
international quality management standards and food safety certifications.
Chuming, with its integrated pork production "cold food" chain is the
first company in China's meat industry to receive "Green Food" Certification
from the Ministry of Agriculture. An innovative project which is unique to
China, the "Green Food" status is an award given to companies who produce food
using environmentally sustainable methods and meet certain technical standards
of quality control, low levels of pollution, safety, and product quality.
Chuming has a unique wholesale-plus-retail distribution model, coupled
with a premium brand and sells fresh, frozen and packaged meat and deli
products directly to thousands of retail outlets including supermarkets and
hypermarkets in China such as Wal-mart, Metro, and Carrefour, three of the
world's top ten retailers. Chuming(TM) products are also sold by Hymall,
owned by Tesco of the U.K, over 3,000 convenience stores, and 500 Chuming(TM)
branded free-standing franchise locations.
According to the U.S. Department of Agriculture, China is the largest pork
producer and consumer in the world, with an estimated $32 billion annual
market. Overall, retail pork prices have nearly doubled in the PRC during the
past 2 years.
Simultaneous with the acquisition on December 31, 2007, the Company
completed a private placement with institutional and accredited investors led
by Pinnacle China Fund, L.P. which resulted in gross proceeds to the Company
of $17.0 million through the issuance of 3,863,636 million shares of common
stock, which represents an approximate 18% stake in the Company. As part of
the private placement, management entered into a "make good" provision whereby
it placed 3,863,636 million of management's shares into an escrow to secure
its obligations to meet specific future after-tax net income targets. In
the event the Company does not achieve its earnings targets of $15.9 million
in after-tax net income ("ATNI") for 2008, and $20.9 million in ATNI and
fully-diluted earnings per share of $0.99 for 2009, then 1,931,818 million
shares held by management, respectively for each year will be transferred on
an all-or-none basis to the investors in the private placement on a pro-rata
basis.
"We are pleased to have completed this financing with a lead investor of
Pinnacle's stature," stated Mr. Huashan Shi, CEO and president of the Company
and Chuming. "The proceeds will be utilized for working capital, to expand
our production capabilities to meet growing market demand, and to broaden our
distribution footprint to include cities surrounding our primary hub of Dalian
City located in the province of Liaoning, where to date we have achieved a 50%
market share in the fresh pork market."
For the nine months ending September 30, 2007, Chuming recorded unaudited
sales of $89.7 million and net income of $8.3 million, compared to sales of
$50.2 million and net income $6.3 million for the first nine months of 2006.
Hunter Wise Securities, LLC acted as the sole placement agent to the
Company and Redwood Capital, Inc. acted as an advisor to Chuming.
About Dalian Chuming Precious Sheen Co., Ltd.
Chuming is a leading regional producer and distributor of fresh and
prepared meat products focusing on pork, the PRC's most consumed meat, in
Northeastern China which has a population of 108 million. Chuming
distributes its premium pork products to more than 3,600 retail locations,
including Wal-mart, Metro, Carrefour, New-mart, Hymall and others, along with
its own network of over 500 Chuming(TM) branded franchise stores. Chuming's
industrialized hog slaughtering, processing and distribution facilities
maintain the ISO 9001 Quality Management System and Hazard Analysis and
Critical Control Point (HACCP) certification. Chuming is the first company
in China's meat industry to receive "Green Food" Certification from the
Ministry of Agriculture.
About "Green Food Certification"
Under strict supervision, control and regulation in production,
processing,
packing, storage and transportation, Green Food applies these quality control
standards from field to table, and regulates the application of inputs,
including pesticide, fertilizer, veterinary drug and additives to minimize
environmental pollution and prevent toxic and harmful substances from entering
the food supply chain. The Green Food certification is based on standards
defined by the Codex Alimentarius Commission ("CAC"), a joint body of the
United Nations Food and Agriculture Organization and the World Health
Organization.
About Hunter Wise
Headquartered in Irvine, California, Hunter Wise Securities, LLC is a
FINRA-registered Broker/Dealer and SIPC Member Firm. Hunter Wise Securities
is wholly owned by Hunter Wise Financial Group, LLC
( http://www.hunterwise.com ), which provides mid-market investment banking
services from eight offices in North America and the United Kingdom. Contact:
Dan McClory, Managing Director (949) 732-4102
About Redwood Capital
Redwood Capital, Inc. ( http://www.redwoodcapinc.com ) assists private
Chinese companies in accessing U.S. capital markets by utilizing a network of
investment banking relationships to achieve reverse merger transactions.
Redwood Capital is a 100 percent-owned subsidiary of S3 Investment Company,
Inc.
Cautionary Statement Regarding Forward Looking Information
This press release may contain forward-looking information about the
Company, Energroup Holdings, Precious Sheen Investments Limited, and its
subsidiaries. Forward-looking statements are statements that are not
historical facts, including targeted net income. These statements can be
identified by the use of forward-looking terminology such as "believe,"
"expect," "may," "will," "should," "project," "plan," "seek," "intend," or
"anticipate" or the negative thereof or comparable terminology, and statements
which may include discussions of strategy, and statements about industry
trends future performance, operations and products of each of the entities
referred to above. Actual performance results in the future may vary
significantly from current expectations and projections as a result of various
factors, including without limitation and the risks set forth "Risk Factors"
contained in the Company's Current Report on Form 8-K filed on January 7,
2008.
The shares of common stock issued in connection with the acquisition and
financing transactions have not been registered under the Securities Act of
1933, as amended, and may not be offered or sold in the United States absent
registration under the Securities Act and applicable state securities laws or
an applicable exemption from those registration requirements. The Company has
agreed to file a registration statement covering the resale of the shares of
common stock issued in the private placement and certain other shares, within
45 days of closing.
This press release does not constitute an offer to sell or the
solicitation of an offer to buy any of the securities referenced herein in any
jurisdiction to any person.
For more information, please contact:
HC International, Inc.
Matthew Hayden
Tel: +1-561-245-5155
Email: Matt.hayden@hcinternational.net
SOURCE Dalian Chuming Precious Sheen Co., Ltd.
Matthew Hayden of HC International, Inc. at +1-561-245-5155 or
Matt.hayden@hcinternational.net
360,500 buys vs 65000 sells
I like it!
With a little News my goodness let me fasten my seatbelt, put my helmet on and pack some clean underwear cause we're taking off!
Now .02 on deck! Sweet!